According to a study, scientists from pharmaceutical trade publish a higher fraction of their papers open access than academics who aren’t in industry. The open-access papers published by 23 large drug companies, such as Pfizer and Roche has overtaken the quantity of liberally available papers published most prominently in medicine-related fields.“It seems like big pharma has a notable niche in open access,” says Kyle Siler, a social scientist at Utrecht University in the Netherlands.
Related Posts
Florida’s Barrier Reef Faces Peril: Scientists Take Urgent Action to Save Coral in Land-Based Tanks
In Florida, the soaring seawater temperatures pose a severe threat to the world’s third-largest barrier reef, prompting scientists to extract coral samples from the ocean and place them in cooler land-based tanks. Surface water temperatures have reached dangerous highs, with the risk of fish and sea turtle die-offs. Non-profit groups are collaborating to collect genetic […]
Elsevier Spindle to Open-Access
Elsevier has approved its first “read-and-publish” contract with a national consortium of universities and research institutions in Norway. The Norwegian consortium has employed an agreement that rolls the two costs into one, apart from paying distinctly to avail content behind paywalls and make the particular articles instantly available to the scientific community. This is a […]
Synthetic melanin: The ultimate skin care solution for sunburns and wounds
Northwestern University researchers have developed a synthetic melanin with potential applications in skin repair and protection. The biomimetic melanin, mimicking natural melanin found in human skin, has shown the ability to accelerate wound healing when applied topically to injured skin. The study, published in Nature npj Regenerative Medicine on November 2, 2023, reveals the synthetic […]